CV Sciences, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
CV Sciences, Inc. (CVSI) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$1.53 million for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2020-08-07
- CV Sciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2020-03-31 was -$2.01M, a 385.92% decline year-over-year.
- CV Sciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2019-03-31 was $703.00K, a 35.86% decline year-over-year.
- CV Sciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2018-03-31 was $1.10M, a 51.59% increase year-over-year.
- CV Sciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2017-03-31 was $723.02K, a 3989.74% increase year-over-year.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed |
|---|---|---|---|---|---|---|
| 2020-06-30 | -$1.53M 10-Q · filed 2020-08-07 | |||||
| 2020-03-31 | -$2.01M 10-Q · filed 2020-05-08 | |||||
| 2019-09-30 | $1.30M 10-Q · filed 2019-11-06 | |||||
| 2019-06-30 | $2.80M 10-Q · filed 2020-08-07 | |||||
| 2019-03-31 | $703.00K 10-Q · filed 2020-05-08 | |||||
| 2018-09-30 | $8.22M 10-Q · filed 2019-11-06 | $8.22M 10-Q · filed 2018-11-07 | ||||
| 2018-06-30 | $4.44M 10-Q · filed 2019-08-07 | $4.44M 10-Q · filed 2018-08-01 | ||||
| 2018-03-31 | $1.10M 10-Q · filed 2019-05-09 | $1.10M 10-Q · filed 2018-05-14 | ||||
| 2017-09-30 | $1.26M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | $840.10K 10-Q · filed 2018-08-01 | |||||
| 2017-03-31 | $723.02K 10-Q · filed 2018-05-14 | |||||
| 2016-09-30 | $328.97K 10-Q · filed 2017-11-08 | |||||
| 2016-06-30 | $889.86K 10-Q · filed 2017-08-11 | |||||
| 2016-03-31 | $17.68K 10-Q · filed 2017-05-09 |